COL4A5 (Gene)

Synonyms:ASLN, ATS, ATS1, CA54, COL4A5, ENTREZ:1287, HGNC:2207, MIM:303630, NM_000495, NM_033380, NM_033381, NP_000486, NP_203699, XM_011530849, XM_017029259, XM_017029260, XM_017029261, XM_017029262, XM_017029263, XP_011529151, XP_016884748, XP_016884749, XP_016884750, XP_016884751, XP_016884752, collagen type IV alpha 5 chain
Omim:OMIM:303630
Id:ENSG00000188153
Hgnc:HGNC:2207
Entrez:1287
Description:collagen type IV alpha 5 chain
This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View COL4A5's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with COL4A5.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using COL4A5.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for COL4A5.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with COL4A5.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.